Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease

W1291 Adalimumab in the Prevention of Postoperative Recurrence of Crohn's Disease

(2010) Ignacio Fernández-Blanco et al.   GASTROENTEROLOGY

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

(2009) Liliana Bordeianou et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients

(2009) Adrian A. Indar et al.   WORLD JOURNAL OF SURGERY

Postoperative Crohn’s disease: prevention and treatment

(2009) Sandra El-Hachem et al.   Expert Review of Gastroenterology & Hepatology

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

(2008) Miguel Regueiro et al.   GASTROENTEROLOGY

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY